Anal Squamous Cell Carcinoma — Trials

Anal Squamous Cell Carcinoma — Trials · CancerIndex

Clinical trials

Registered studies

51 studies whose conditions map to this entity or one of its descendants. Status and phase are as posted on ClinicalTrials.gov. 50 studies per page.

Active: 24
Recruiting: 13
Ph III recruiting: 1
Growth YoY: —
Industry share: 21%
Top sponsor: National Cancer Institute (NCI)
Termination share: —

Computedformula ci-trial-intel-v1 · interventional studies · entity + NCIt descendants · hover a figure for its formulaCompare cancers Terminated studies (3)

clinicaltrialsPublishedShowing 1–2 of 2 studies matching the filters · status and phase as posted by the registrant; each row links to the study record.

NCT	Title	Status	Phase	Enrollment (n)	Sponsor	Countries	Last update	Source
NCT04596033	TiTAN-1: Safety, Proliferation and Persistence of GEN-011 Autologous Cell Therapy	terminated	Phase 1	49	Genocea Biosciences, Inc.INDUSTRY	1	Jul 15, 2022	clinicaltrials
NCT02407561	Prospective Validation Study for the Proprietary Rectal and Anal Cancer Protein Expression Assays	terminated	—	3	Castle Biosciences IncorporatedINDUSTRY	1	Jan 25, 2018	clinicaltrials